Clinical Trials Directory

Trials / Completed

CompletedNCT03297580

Itch and Clinacal Caracteristics in Systemic Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Systemic sclerosis (SSc) has heterogeneous symptoms and significant medical morbidity. Recently, itch was described as a symptom of SSc (prevalence of 42,6%). To the investigators knowledge, no study yet has examined the clinical features of itch neither had used a specific itch-related quality of life (QoL) scales in patients with SSc. The objectives were to evaluate the prevalence of pruritus, its characteristics and its impact on the QoL in those patients. In this descriptive study, patients followed for SSc in the departments of dermatology, rheumatology, internal medicine and pulmonology at the University Hospital of Brest were included. Participants received a questionnaire including questions about the clinical features of pruritus and 2 scores (5-D itch scale, ItchyQol).

Conditions

Timeline

Start date
2016-02-01
Primary completion
2016-03-31
Completion
2016-03-31
First posted
2017-09-29
Last updated
2017-09-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03297580. Inclusion in this directory is not an endorsement.

Itch and Clinacal Caracteristics in Systemic Sclerosis (NCT03297580) · Clinical Trials Directory